Rare lephants
Screener

Aytu BioPharma, Inc.

AYTU ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Oct 22, 2026 FORM DEF 14A
10-K Sep 22, 2026 FORM 10-K
8-K Sep 22, 2026 FORM 8-K
SCHEDULE 13G/A Aug 14, 2026
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
4 Jul 30, 2026 FORM 4
8-K Jun 25, 2026 FORM 8-K
10-Q May 13, 2026 FORM 10-Q
8-K May 13, 2026 FORM 8-K
8-K Apr 2, 2026 FORM 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
10-Q Feb 3, 2026 FORM 10-Q
8-K Feb 3, 2026 FORM 8-K
8-K Jan 20, 2026 FORM 8-K
8-K Dec 10, 2025 FORM 8-K
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 13, 2025 FORM 10-Q
8-K Nov 13, 2025 FORM 8-K
← Newer Page 1 of 37 · 906 filings Older →